Reducing poverty and spurring growth in developing countries requires strategic, high-value investment of scarce resources, whether they come from donors, governments, or communities.
Evidence Action develops and de-risks business models for such programs that allow tens of millions of people to be served, and return on investment to be measured.
We bridge the gap between rigorous research and pilot programs on the one hand, and institutionalized programs on the other. By focusing on promising approaches backed by rigorous evidence, we support programs that are measurably effective; by seeking to solve the challenge of scale, we provide cost-effective impact for many.
Evidence Action launched formally in 2013 to scale programs with sustainable business models that have been proven to be effective in order to benefit millions of people.
Evidence Action leads and manages two programs incubated initially by Innovations for Poverty Action: Dispensers for Safe Water and the Deworm the World Initiative. While Evidence Action grew out of a need to manage these two programs, the larger goal of the organization was to successfully bridge the gap between proven interventions that work and scaling them up to produce measurable impact for millions of people. This led to the creation of Evidence Action Beta in 2014, where we are currently testing a number of other rigorously-evaluated interventions for to be implemented as sustainable programs at scale.
Evidence Action is dedicated to improving the lives of millions of people across Africa and Asia. Our approach fills the gap between research about "what works" and solutions for people in need. We operate in ten countries across the globe and positively impact hundreds of millions of lives every year in a measurable way by delivering our evidence-based interventions where the need and opportunity are greatest.
We provide services to the most vulnerable people in these countries irrespective of their race, religion, gender, or political affiliation. Some of the countries where we operate are representative democracies while others are not. Our operations in a given country in no way reflects an endorsement of that country's form of government, and we continuously evaluate the political situation wherever we operate.
What makes Evidence Action unique is our process: we spend much of our energy identifying evidence-based interventions, pressure-testing them for scalable feasibility, and designing them to serve millions. We identify innovative, appropriate financing mechanisms and build best practice operational models (prototyping). We voraciously self-evaluate, learn, and improve our models for scaling with a commitment to transparency on progress, impact, and value for money.
We lead with our values, putting evidence first. By going where the evidence leads us, it allows our decision making process--how we choose which innovations to scale up and how to constantly evaluate them--to produce programs that give the biggest bang for your buck.
Building a world where hundreds of millions of people in the poorest places have better opportunities and their lives are measurably approved.
Evidence Action aims to be a world leader in scaling evidence-based and cost-effective programs to reduce the burden of poverty.
Evidence first. We are led by the facts. We go where the data takes us. Robust, rigorous evidence informs our choices and decisions.
Think big, act urgently. We are unrelenting in our pursuit of results at scale. We know that poverty does not wait. We act so that the best ideas deliver benefit to millions.
Iterate, again. We reflect constantly and adapt accordingly. We test,measure, and improve to ensure impact. If we can do something, we can do it better.
Economize without compromise. The biggest impact at the lowest cost is what we are after. We ensure value for money for all our stakeholders, but know there is no substitute for quality.
Challenge convention. We ask “why” and “why not” in equal measure. We are sincere in our skepticism and incessant in our search for solutions.
Passion throughout. We are driven to lessen inequality, to improve lives. We take action, converting impatience into impact.
Evidence Action is grateful for the leadership and counsel of our Board of Directors and Advisors. They lead us to live up to our organizational values of rigor, evidence, and action. We greatly appreciate the considerable commitment and time that they contribute.
Amrita Ahuja is a founder of Evidence Action. An accidental social-entrepreneur, she led the the start-up of Dispensers for Safe Water, and chaired the board of Deworm the World as it grew to reach 30 million children. She leads the Douglas B. Marshall, Jr. Family Foundation, an innovative funder of international education. Ahuja also worked as a Management Consultant for the Monitor Group where she led projects to evaluate market-based approaches to delivering products and services to the poor. There she developed consumer marketing strategies, distribution models, and best practices for health and other products. Ahuja brings experience in marketing and distribution of consumer goods in the public and private sectors in India and Africa as well as significant experience with innovation and evidence in international development. She holds a Ph.D. in Business Economics from Harvard University.
Kanika Bahl is CEO of Evidence Action where she has been on the Board since 2015. Previously she served as Managing Director at Results for Development (R4D), where she established and led the Market Dynamics practice. The practice has increased access to products such as childhood pneumonia treatments and malaria bed nets for millions of individuals in Africa and Asia. It achieves this by aligning the interests of manufacturers, donors, and country governments to develop and execute healthcare solutions for under-served markets at scale.
Kanika is on the Board of TechnoServe and previously acted as Market-Shaping Co-Chair for the UN Commission on Life Saving Commodities. Prior to R4D, Kanika served as an Executive Vice President at the Clinton Foundation Health Access Initiative (CHAI). Kanika received her MBA from the Stanford Graduate School of Business and her BA in Mathematical Economics from Rice University.
Shikhar Ghosh is currently a Professor of Management Practice at Harvard Business School. Shikhar has been a successful entrepreneur for the last 20 years. He was the founder and CEO or Chairman of eight technology-based entrepreneurial companies and was the past Chairman of the Massachusetts Technology Leadership Council and The Indus Entrepreneurs. He was selected by Business Week as one of the best Entrepreneurs in the US, by Forbes as one of the ‘Masters of the Internet Universe’ and by Fortune as the CEO of one of the 10 most innovative companies in the US.
John Gianola is a retired partner from Ernst & Young, one of the leading global accounting firms. During his 38 year career, 27 as an audit partner, he had supervisory responsibility for engagements involving accounting and auditing for a variety of industries including banking, insurance, energy, mining, manufacturing, technology, not for profit and governmental entities. John’s clients were both publicly and privately owned, ranging in size from small entities to multi-national Fortune 500 companies with subsidiaries operating in multiple jurisdictions around the world. John lead continuing education courses for Ernst & Young executives, was a guest lecturer in college classrooms, and served as an adjunct professor of accounting at West Virginia University. John is a member of the American Institute of Certified Public Accountants, the West Virginia Society of Certified Public Accountants, the Board of Advisors of The College of Business and Economics at West Virginia University and the West Virginia University Foundation.
Dina Pomeranz is an expert on impact evaluations and studies public policies in developing countries, with a particular focus on taxation and public procurement. She is a faculty research fellow at the National Bureau of Economic Research (NBER), an affiliate professor at the Abdul Latif Jameel Poverty Action Lab (J-PAL), the Bureau for Research and Economic Analysis of Development (BREAD) and the Center for Economic Policy Research (CEPR). She is also a member of the International Growth Centre (IGC) and the HBS Social Entreprise Initiative. Besides her academic interests, she serves on the boards and advisory boards of a number of social enterprise ventures committed to translating research into practice.
Christina Riechers is passionate about building innovative business models with social benefit. In her current role she makes commerce easier for small businesses at Square, the financial services and payments start-up. A co-founder of Evidence Action, Christina was previously Evidence Action’s Director of Global Programs as well as Director of Business Development and Strategy. In these capacities, she was a key player in Evidence Action’s start-up phase, generating resources for the organization, creating a vision for growth, and establishing organizational systems. Prior, Christina worked with d.light design to make solar lighting affordable to rural households in India. She was also a management consultant for Bain & Company where she advised clients on strategy and operations.
Christina has a MBA from MIT Sloan and MPA/International Development from Harvard Kennedy School.
Sam Taylor is an equity analyst at Fidelity, where he identifies attractive investment opportunities for ownership across Fidelity's family of funds. His research leverages expertise in business strategy and accounting, as well as regional specialization in African and Latin American markets. Previously, he was a management consultant at Oliver Wyman and Mesoamerica Investments, advising clients in the U.S., Mexico, and Central America on business strategy. Taylor holds an MBA from The Wharton School.
David Addiss is the Director of the Children Without Worms program at the Task Force for Global Health. Addiss previously was a Senior Program Officer at the Science and Spirituality Program at the Fetzer Institute in Michigan where he was responsible for directing and planning Fetzer’s research program. Addiss spent 20 years at CDC where he conducted research on the prevention and control of parasitic diseases, with an emphasis on lymphatic filariasis and other neglected tropical diseases. He co-founded and co-directed the World Health Organization’s Collaborating Center for Control and Elimination of Lymphatic Filariasis in the Americas, based at CDC. Addiss received an M.D. from the Medical College of Georgia and an M.P.H. from Johns Hopkins University.
Steffano Bertozzi is a Professor and Dean of the School of Public Health at the University of California at Berkeley. He has led impact evaluations of large, national health and social programs in Mexico as well as in Africa, Asia and Latin America. His research has covered a diverse range of projects in health economics and policy, focusing on the economic aspects of HIV/AIDS and on the health impact of large social programs. Bertozzi was previously the director of the HIV Global Health Program at the Bill and Melinda Gates Foundation. He holds a Ph.D. in health policy and management from the Massachusetts Institute of Technology and earned his medical degree at UC San Diego.
Iqbal Dhaliwal is the Deputy Director of The Abdul Latif Jameel Poverty Action Lab and its global head of Policy. Mr. Dhaliwal works with policy makers in governments, international development organizations, foundations, and NGOs to help identify new field evaluations and implement the scale-up of successful programs in developing countries. Before coming to J-PAL, Dhaliwall was a Director in the Economic Analysis practice of a consulting firm in Boston. He was also a member of the Indian Administrative Service where he worked as a Deputy Secretary in a state government, as a Director of a state-wide welfare department, and as Managing Director (CEO) of a publicly owned company.
Stephen Luby is Professor of Medicine in the Division of Infectious Diseases and Geographic Medicine at Stanford University and Deputy Director for Research at the Center for Global Health Innovation. He previously served at the International Centre for Diarrhoeal Diseases Research, Bangladesh where he directed the Centre for Communicable Diseases exploring causes and prevention of diarrheal disease in settings where diarrhea is a leading cause of childhood death. Luby holds a medical degree from the University of Texas Southwestern Medical School at Dallas. He studied epidemiology and preventive medicine at the Centers for Disease Control and Prevention.
Hari Menon is a Deputy Director at the Bill and Melinda Gates Foundation, where he works on policy, advocacy and government relations in India. Previously, Mr. Menon was the Deputy Director of India Country Office Programs for the Foundation where he supported a wide portfolio of work in public health in areas such as HIV prevention, and maternal and child health. Prior to joining the Gates Foundation, he served as strategic philanthropy adviser to Rohini Nilekani, a leading Indian philanthropist in areas including water & sanitation, environment conservation, education and governance & accountability. He holds an MBA in Marketing and Finance from XLRI, Jamshedpur, India.
Mushfiq Mobarak is an Associate Professor at Yale University with interests in environment and public finance issues. He has two main lines of research: (1) field experiments exploring ways to induce people in developing countries to adopt technologies or behaviors that are likely to be welfare improving, and (2) using field experiments and other methods to study the management of water resources and other infrastructure. He has experiments on migration, infrastructure (roads and electricity), water user associations, rainfall insurance, and environmental technologies (stoves, rainwater harvesting, conservation agriculture) ongoing in Bangladesh, India, Malawi, Nigeria and Uganda. Mobarak holds a Ph.D. in Economics from the University of Maryland.
Erik Nielsen is a Senior Advisor in the Partnerships for Development Innovation branch of Foreign Affairs, Trade and Development Canada. Mr. Nielsen has wide-ranging experiences as a development practitioner working across multinational agencies, international NGOs and government development assistance. He specializes in evidence-based policy advocacy, and coalition and partnership building. Nielsen holds a Ph.D. in International Economic Policy from the Massachusetts Institute of Technology (MIT), and was a Research Fellow at Harvard University.
Henk van Stokkom is a long-time entrepreneur and philanthropic advisor. He currently guides foundations and families in structuring and implementing charitable investments. Previously, he was the managing director of an investment company active on the Dutch stock exchange. Van Stokkom has worked for a number of companies such as Salomon Smith Barney Netherlands where he was involved in launching investment products (Managed Futures, Socially Responsible Investment, Emerging Market Debt & Private Equity/Venture Capital) for institutional investors, and has held positions as financial director for the De Waal Foundation and Hemar BV. For the De Waal Foundation, he was active in Latin America where the foundation was (co-) financing projects for children with disabilities. Van Stokkom has served on the boards of several charitable organizations including as chairman of Stichting Beheer Oikocredit Nederland Fonds (2002 -2006), a Dutch investment fund for micro credit.
In addition to helping us as we expand our work, our advisors guide us on how to improve the cost-effectiveness and sustainability of existing programs. We anticipate adding further advisors over the next months.
Grace Hollister, Global Director, Deworm the World Initiative
Pompa Debroy, Associate Director, Deworm the World Initiative
Kate McCracken, Senior Manager, Deworm the World Initiative
Paul Monaghan, Program Manager, Vietnam
Karen Levy, Director, Global Innovation and Beta
Samantha Bastian, Deputy Director, Beta
Mike Dalious, Beta Program Director
Karim Naguib, Staff Economist
Kanika Bahl, Chief Executive Officer
Steve Denne, Chief Operating Officer
John de Wet, Chief Financial Officer
Moses Baraza, Program Lead, Kenya
Richard Kibuuka, Program Lead, Uganda
Express Moyo, Program Director, Malawi
Priya Jha, Director
Deepak Yadav, Associate Director of Programs
Laliteswar Kumar, Director, Africa Region
Evans Ithiria, Regional Director, Finance and Administration
Paul Byatta, Associate Director, Monitoring, Learning & Information Systems
Evidence Action started formally in 2013 when we began leading and managing Dispensers for Safe Water and the Deworm the World Initiative. The full transition from Innovations for Poverty Action which incubated both programs, took place in 2014.
Our program expenses and revenue are detailed in our most recent financial documents:
We are also grateful for the support of individual investors, and welcome your support. You can donate to Evidence Action here. Thank you!
Evidence Action is a nonprofit 501(c)(3) organization in the United States, and contributions to us are tax deductible in the U.S. to the fullest extent allowable by law. Our EIN number is 90 087 4591.
Our determination letter issued by the Internal Revenue Service is here.
In 2013, Evidence Action was supported by the following institutional investors:
In 2014, Evidence Action was supported by the following institutional investors:
In 2015, Evidence Action was supported by the following institutional investors: